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Abstract 
Background:Venous thromboembolism is an important complication of major 
orthopedic surgery. 
Objective: To investigate the efficacy of the currently used thromboprophylaxis 
protocol, determine the incidence of VTE post operatively and the risk factors 
behind it in patients undergoing major orthopedic surgery. 
Method: A retrospective descriptive study for 403 patients underwent major 
orthopedic surgery from July 2013 to July 2014 in main hospitals in Khartoum state 
where major orthopedic surgery performed. Data were collected using observation 
checklist and analyzed using SPSS version 22 to study the association between the 
type of surgery, patient’s risk factors, choice and duration of thromboprophylaxis 
and development of VTE after major orthopedic surgery. 
Results: 403 patients was incorporated the study, 2.73% were diagnosed with DVT 
developed within 5 days post operatively. 1.64% of the patients not received any 
type of thromboprophylaxis, 0.27% wore compression stocking. Pharmacological 
methods were used in the rest of the patients, 96.72% administered to them 
enoxaparine. 
75.95% of the patients presented with one or more than one risk factors for VTE 
other than the orthopedic surgery. 4% of patients received thromboprophylaxis 
formore than 14 days while 96% received it for 3-5 days. The incidence of DVT was 
higher in diabetic patients (p- value= 0.03) and hypertensive (p- value= 0.046) who 
aged ≥60 years.  
Conclusion:  Results showed that VTE was a significant complication of major 
orthopedic surgery, despite the use of thromboprophylaxis and the incidence was 
2.73% in our study. 
 
Introduction: 
Major surgical procedures put patients in a hypercoagulable state by altering 
hemodynamic stasis from immobility and mechanical vascular damage from the 
operative intervention. Orthopedic procedures such as hip fracture surgery (HFS), 
total hip replacement (THR) and total knee replacement (TKR) are thought to be 
  
 
particularly problematic owing to the physical and mechanical impact on the venous 
system of the lower limb. Other types of major orthopedic surgery for spinal or 
upper limbs are not contributed to thrombogenic risk.
 (1, 2) 
The type of anesthesia used also can influence thromboembolic risk as general 
anesthesia increase the thromboembolic risk and in the other side inappropriate 
administration time of antithrombic drugs with spinal anesthesia exposed the 
patients to risk of hematoma.
(3) 
 
Clinical or patient independent factors that increase the risk of venous 
thromboembolism include a history of previous Deep Venous Thrombosis (DVT), 
age, use of oral contraceptives, pregnancy, and comorbidity, cancer, myocardial 
infarction, and stroke are associated with a high risk of venous 
thromboembolism.Therefore, a combination of predisposing surgical and patient risk 
factors for Venous Thromboembolism (VTE) may result in a higher rate of DVT in 
orthopedic surgery if no prophylaxis is given.
 (4, 5)
 
Thromboprophylaxis can take the form of mechanical, pharmacologic, and/or 
ancillary means. Mechanical methods include anti- embolism stockings, foot 
impulse devices, and intermittent pneumatic compression devices (IPC). Depending 
on the patient medical state and presence of contraindications, pharmacological VTE 
prophylaxis can be applied using Low Molecular Weight Heparin (LMWH), 
unfractionated heparin (UFH), and other anticoagulants (such as Vitamin K 
antagonists (VKAs), apixaban, dabigatran, fondaparinux, and rivaroxaban). 
Ancillary methods include early mobilization and prevention of dehydration. 
The ninth update of the American collage of chest physician ACCP guidelines in 
February 2012 recommends pharmacological thromboprophylaxis with an IPC 
device for THR or TKR, with LMWH being preferred as the first-line option over 
other pharmacological agents. The recently updated ACCP guidelines also 
recommend extending the duration of thromboprophylaxis for 28 to 35 days 
following THA or hip fracture surgery as the risk for venous thromboembolism 
persists for up to 3 months after surgery. Extended-duration thromboprophylaxis (up 
to 6 weeks) with low molecular weight heparin is significantly more effective in 
preventing venous thromboembolism in major orthopedic surgery.
(6)
 
The national institute of health and care excellence NICE guidelines emphasizes 
mechanical intervention at admission prior to the surgery as well as pharmacological 
prophylaxis after THR (for 28–35 days) and TKR (for 10–14 days). 
Despite the recommendations of current guidelines and availability of effective 
thromboprophylaxis medications, it is inadequately used in clinical practice 
especially in major orthopedic surgery (THA, TKA, or hip fracture surgery) even 
  
 
with no presence of contraindications which contributes to observation of many 
cases developing DVT that necessitate a long term expensive treatment.
(7)
 
Objectives: To investigate the efficacy of the currently used thromboprophylaxis 
protocol and determine the incidence of VTE post operatively and the risk factors 
behind it in patients undergoing major orthopedic surgery. 
Methods:  
Study design: 
A retrospective descriptive study for 403 patients from July 2013 to July 2014 using 
records obtained from health services administrative databases.  
The demographic database provides information on age, weight and sex. Procedure 
instruction provides information on type of surgery, type of anesthesia used and 
onset of thromboprophylaxis initiation. 
Patient record provides information about independent risk factors, age, obesity, 
pregnancy, comorbidity, cancer, previous DVT, myocardial infarction and stroke. 
Follow up records provides information on drugs used for thromboprophylaxis, the 
dose, administration, duration of thromboprophylaxis and clinical monitoring for 
signs and symptoms of VTE. 
Study area:  
Main hospitals in Khartoum state where major orthopedic surgery performed: 
ShargAlnail Hospital, Saheron Hospital, Omdurman Military Hospital, 
Alribatteaching hospital and Bahri teaching hospital 
Data collection and analysis:  
The data were collected by using observation checklist and analyzed using the 
Statistical Package for the Social Sciences for Windows SPSS version 22to study the 
association between the type of surgery, patient’s risk factors, choice and duration of 
thromboprophylaxis and development of VTE after major orthopedic surgery. 
Results:  
The data of 403 patients were assessed; the information was collected from five 
hospitals in which the major orthopedic surgery performed. (Table 1) 
Table 1:Distribution of study sample according to hospital 
Hospital   Frequency Percent )%(   
SherqAlneel 131 32.5 
Bahry 60 14.9 
Alshorta 46 11.4 
AlslahAltiby 118 29.3 
Sahiroon 48 11.9 
Total 403 100.0 
  
 
 
The proportions of knee arthroplasty, hip arthroplasty, femur fracture and pelvic 
fracture repair were 28.3%, 16.9%, 42.9% and 11.9% respectively. The mean age of 
the patients was 55.36 ± 18.77 years. Male encountered 63 % while female were 
37%. General anesthesia was administered in 9% of the patients where as 91% were 
treated with combined spinal – epidural anesthesia. (Table 2) 
Table2: Demographic data, type of surgery, and type of anesthesia used in the 
patients included in the study (n=403) *: 
Variable Result 
Age (year) 55.36 ± 18.77 
Gender  
254 (63.0%) 
149 (37.0%) 
Male 
Female 
Type of surgery    
116 (28.8%) 
114 (28.3%) 
173 (42.9%) 
Hip arthroplasty 
Knee arthroplasty   
Femur fracture repair 
Type of anesthesia  
37 (9.2) 
366 (90.8%) 
General  
Combined 
*Value expressed as mean ± SD. 
 
6 (1.64%) of the patients not received any type of thromboprophylaxis, 1(0.27%) 
wore compression stocking only without presence of a contraindication to the 
pharmacological thromboprophylaxis. Pharmacological methods were used in the 
rest of the patients, 354 (96.72%) patients enoxaparine was administered, tinzaparin 
used in 2 (0.55%), aspirin in 1 (0.27%) and 2 (0.55%) received aspirin plus 
enoxaparin. The dose of enoxaparin used in these cases was 40 mg/day 
subcutaneously (SC), tinzaparin 4500 IU administered SC per day and 100 mg 
aspirin orally per day. 
The prophylaxis started before surgery with no available records about the exact 
time of administration. There were no cases reported with bleeding complications 
due to Thromboprophylaxis. 
306 (75.95%) of the patients presented with one or more than one risk factor for 
VTE other than the orthopedic surgery. Additional risk factors for VTE are included 
in (Table 3). 
Table 3: Distribution of potential risk factors other than major orthopedic surgery 
for venous thromboembolism 
  
 
Additional risk factors Study sample (n=403) 
Age ≥40 years 278 (69%) 
Previous history of  DVT 11 (2.7%) 
Malignancy 0 
Hormone therapy 3 (0.7%) 
Pregnancy 1 (0.2%) 
Comorbidity  
83 (20.6%) 
118 (29.3%) 
5 (1.20%) 
Diabetes mellitus 
Hypertension 
Dyslipidemia 
Stroke 5 (1.20%) 
Myocardial infarction 0 
Others* 12 (3.00%) 
*sickle cell disease or Hyperthyroidism 
Thromboprophylaxis for more than 14 days was implemented in 13 (4%) while in 
349(96%) of the cases was administered for short term, most of them until patient 
discharged (for 3-5 days). 
Of the 403 patients, 11(2.73%) were diagnosed with DVT. Majority of the patients 
who had DVT, it was developed within the first 5 days postoperative. The time for 
onset of DVT in the patients is shown in Table 4. 
Table 4: Time per day for the onset of deep vein thrombosis in the study sample 
Statistics of (Onset of thrombosis post 
operatively) 
Number of patients 11 
Mean 5.8182 
Median 5.0000 
Std. Deviation 2.40076 
Minimum 3.00 
Maximum 10.00 
 
The majority of patients (10) who developed DVT were aged ≥ 60 years, one patient 
who is 18 years had a sickle cell disease. No significant differences were found 
regarding the gender or the type of the surgery in the group of patients who 
developed DVT (p- value> 0.05).  
The analysis revealed that the patients received general anesthesia (p- value =0.012) 
were at a greater risk for the development of DVT than those who had spinal 
anesthesia.  
The incidence of DVT was higher in diabetic patients (p-value = 0.03) and 
hypertensive (p- value = 0.046). However, the incidence of thromboembolism in 
  
 
patients with a previous history of DVT, stroke, hormone replacement therapy or 
dyslipidemia was not significantly higher than in other patients (p - value>0.05 for 
all). 
81.8 % of the patients developing DVT received the Thromboprophylaxis for 3 days 
with no significance difference regarding the choice of drug. One patient not 
received the therapeutic dose of DVT was died as a result of thromboembolism, 
leading to a mortality rate of 0.24%. 
 
Table 5. Factors influencing the development of thromboembolism in patients 
undergoing major orthopedic surgery: 
Factor At 95% Cl.      P– value 
Type of anesthesia 
  General anesthesia 
 
 -0.721-               0 .012 
Age≥ 60 years  -1.074-                0.040 
Duration of Thromboprophylaxis 
˂ 14 days 
 
-1.185-                0.027 
Additional risk factors 
   Diabetes mellitus 
Hypertension 
 
    -0.650-                0.03 
   -0.610-                0.046                             
 
Discussion: 
The incidence of thromboembolism in patients following major orthopedic surgery 
was 2.73%, most of them developing DVT within 5 days post operatively. The use 
of prophylaxis decreased the incidence but did not completely resolve the problem.  
In one meta-analysis, it was reported that the incidence of PE within 3 months after 
the procedure was 3.2% in patients receiving short-term prophylaxis (7-10 days).
(9)
 
The incidence of DVT in patients who did not received thromboprophylaxis was 
16.66% , this rate is lower than the reported rates (40-60%)
(10)
 ,the reason may was  
the majority of them presented with no additional risk except the risk of surgery 
only, and the age group was less than 40 years. 
Our analysis revealed that the patients received general anesthesia (p- value =0.012) 
were at a greater risk for the development of DVT than those who had spinal 
anesthesia, this found to be complied with a meta-analysis conducted by Hu et al. 
(2009) of 21 randomized clinical trial and the result was that compared with general 
and local anesthesia for total knee replacement (TKR) or total hip replacement 
(THR) was associated with a reduced incidence of both DVT (OR = 0.45; 95% CI 
0.24 to 0.84; ten RCTs of 910 patients) and PE (OR = 0.46; 95% CI 0.29 to 0.80; 
eight RCTs of 747 patients). The search encompassed a wide date range and some 
  
 
included studies were performed in the 1980s when differences in surgical 
techniques may limit relevance to modern practice.
 (8)
 
Even in high risk groups, in all the hospitals included in the sample, there were no 
special considerations regarding method, choice of drug or the duration of 
thromboprophylaxis. No method for patients risk stratification was implemented to 
assess the cases. 
The practice of the hospitals in the current study was inconsistent with the ACCP 
recommendations with regard to the method and time of initiation of 
thromboprophylaxis after major orthopedic surgery and inconsistent with regard to 
extend the duration of thromboprophylaxis especially in high risk patients. Most of 
hospitals in this study administered thromboprophylaxis for 3-5 days only. 
Conclusion:  
The incidence of venous thromboembolism in patients following major orthopedic 
surgery was 2.73%, most of them developing DVT within 5 days post operatively 
despite the use of mechanical interventions and pharmacological prophylaxis, 
venous thromboembolism is an important complication of major orthopedic surgery, 
and the risk is higher in: Patients who aged ≥60 years, Diabetic patients, 
hypertensive patients, patients received short term thromboprophylaxis ˂14 days and 
Patients whose orthopedic surgery performed under general anesthesia. 
Clinicians should implement to a risk stratification model and an evidence based 
protocol and be aware of VTE, especially in elderly patients (≥ 60 years of age) who 
present with comorbidity and extend the thromboprophylaxis duration in the high 
risk patients. 
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